StemGenex® Positions Itself Among Best Stem Cell Centers in U.S.
Safety, Efficacy, Patient Satisfaction Drive StemGenex’ Efforts toward Best-in-Class Stem Cell Treatment
LA JOLLA, Calif., April 1, 2014 /PRNewswire/ — StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue to benefit from the ground breaking studies being conducted.
“Patient safety will always be the primary focus at StemGenex,” said Rita Alexander, President of StemGenex. Dr. Jeremiah McDole was recently brought on as Director of Clinical Research and Development. In this role he will be directly responsible for all clinical programs including oversight of the entire laboratory process. By utilizing Dr. McDole’s scientific research background, StemGenex believes it will further advance its protocols to the benefit of every patient.
StemGenex also believes the most effective treatment is attained by utilizing top-tier physicians. All treatments offered through StemGenex are performed by U.S. board certified physicians. These physicians are studying multiple cutting-edge treatment options such as intranasal administration where neurological patients can receive stem cells non-invasively, which directly target the brain.
Patient satisfaction is also a primary focus of StemGenex. StemGenex is the only stem cell organization that actively tracks their patient satisfaction ratings, proudly displaying them on their website. StemGenex works tirelessly to provide the absolute highest level of care for patients and is very proud of the overwhelmingly positive results from these surveys. This is just one of the many ways that StemGenex continues to innovate and position itself as the premiere resource for adipose stem cell therapy in the U.S.
Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with Multiple sclerosis and other degenerative neurological diseases. StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative neurological diseases including Parkinson’s and Alzheimer’s disease, stroke recovery and others. Rita Alexander, founder of StemGenex and the company’s first stem cell patient, insists that all patients be treated like they are one of our loved ones. “Hope, compassion, and the relentless pursuit for an end to these diseases are the primary focus.”
To find out more about stem cell therapy, contact StemGenex either by phone at (800) 609-7795 or email Contact@stemgenex.com
Contact: Joseph Perricone, 858-459-7836, email@example.com